Placeholder Banner

BIO Stands United with the President's Goal of Ending Cancer

February 2, 2022
Media Contact
JG

The following statement can be attributed to BIO's President and CEO Dr. Michelle McMurry-Heath:

“President Biden has long been a champion of research to end cancer. He reaffirmed that commitment today with the relaunch of the "Cancer Moonshot."

"Though details are still forthcoming, BIO welcomes this initiative and stands united with the President's goal of ending the untold human suffering from cancer.

"In the coming weeks, we look forward to working with the White House as it develops a long-term strategy, especially as it relates to understanding the effects of all healthcare policies on the development of future cancer cures."

Discover More
Today the dispute settlement panel formed under the United States-Mexico-Canada Agreement (USMCA) issued a final ruling related to Mexico's restrictions on the importation of genetically modified (GM) corn. In response, John Crowley, President…
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), today released the following statement ahead of an expected vote in the U.S. House of Representatives on a year-end government funding bill that includes many…
Today, the Biotechnology Innovation Organization (BIO) named Sarah Alspach as its new executive vice president and chief communications officer. Alspach, a communications veteran, will join BIO’s senior leadership team. Her first day will be…